Drug Gives Hope to Parkinson's Disease Victims
Posted on: Friday, 10 December 2004, 18:00 CST
ONE of the most distressing symptoms of Parkinson's disease can be treated, a major British trial suggests.
A drug normally given to sufferers from Alzheimer's disease has been shown to be effective against dementia.
Parkinson's chiefly affects the brain's motor neurons, causing rigidity, shaking and lack of balance. But two out of five victims also develop dementia.
A trial on 541 patients, including 52 from the UK, showed that those taking the Alzheimer's drug rivastigmine tartrate had significantly fewer dementia symptoms.
Dr Jane Byrne, from Wythenshawe Hospital, Manchester, who led the UK arm of the study, said: 'This is the first large-scale trial of its kind to show that PDD (Parkinson's disease dementia) can be treated.
Until now, previous studies have been very small scale.'
Source: Daily Mail; London (UK)
Related Articles
- Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials
- Sleep Disorder Could be an Early Sign of Dementia or Parkinson's Disease
- XenoPort Reports Encouraging Results of Phase I Parkinson's Trial
- Research and Markets: 2007 Trial TRAX - Alzheimer's Disease - Clinical Trial Monitoring Brief Provides Detailed Compilations And Analysis Of Ongoing Studies
- Creatine Parkinson Trial Begins
- BrainStorm Starts Preclinical Parkinson's Trial
- Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
- Antipodean Begins Phase II Parkinson's Trial
- Initiation of Largest Disease Modification Trial to Study Effect of AGILECT(R) in Slowing Progression of Parkinson's Disease
- Avigen Announces Encouraging Early Data From Parkinson's Disease Clinical Trial
 |
 |
User Comments (0)
RSS Feeds